Nabih Maslah

776 total citations
30 papers, 458 citations indexed

About

Nabih Maslah is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Nabih Maslah has authored 30 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 22 papers in Hematology and 14 papers in Rheumatology. Recurrent topics in Nabih Maslah's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (26 papers), Eosinophilic Disorders and Syndromes (14 papers) and Acute Myeloid Leukemia Research (13 papers). Nabih Maslah is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (26 papers), Eosinophilic Disorders and Syndromes (14 papers) and Acute Myeloid Leukemia Research (13 papers). Nabih Maslah collaborates with scholars based in France, United States and Austria. Nabih Maslah's co-authors include Bruno Cassinat, Emmanuelle Verger, Jean‐Jacques Kiladjian, Stéphane Giraudier, Laura Evelia Torres Velázquez, Christine Chomienne, Marie‐Hélène Schlageter, Pierre Ly, Cécile Bally and Jacqueline Lehmann‐Che and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and British Journal of Haematology.

In The Last Decade

Nabih Maslah

27 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nabih Maslah France	11	298	290	217	163	61	30	458
Christine Zoi Greece	6	336 1.1×	275 0.9×	226 1.0×	127 0.8×	24 0.4×	10	429
Irène Dobo France	10	377 1.3×	286 1.0×	228 1.1×	165 1.0×	48 0.8×	20	480
Yoshitaka Sunami Japan	10	307 1.0×	263 0.9×	246 1.1×	70 0.4×	39 0.6×	18	449
Jacob Grinfeld United Kingdom	11	277 0.9×	228 0.8×	177 0.8×	112 0.7×	28 0.5×	19	365
Ronan Chaligné France	8	324 1.1×	296 1.0×	223 1.0×	106 0.7×	45 0.7×	12	439
Jiřı́ Schwarz Czechia	11	249 0.8×	245 0.8×	220 1.0×	64 0.4×	31 0.5×	36	403
J. Janssen Netherlands	9	222 0.7×	285 1.0×	75 0.3×	111 0.7×	70 1.1×	11	412
Marie Colombat France	2	249 0.8×	353 1.2×	85 0.4×	300 1.8×	55 0.9×	4	488
Karl Haslam Ireland	8	142 0.5×	130 0.4×	101 0.5×	87 0.5×	49 0.8×	30	267
Mythri Mudireddy United States	14	870 2.9×	808 2.8×	470 2.2×	254 1.6×	22 0.4×	25	948

Countries citing papers authored by Nabih Maslah

Since Specialization

Citations

This map shows the geographic impact of Nabih Maslah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nabih Maslah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nabih Maslah more than expected).

Fields of papers citing papers by Nabih Maslah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nabih Maslah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nabih Maslah. The network helps show where Nabih Maslah may publish in the future.

Co-authorship network of co-authors of Nabih Maslah

This figure shows the co-authorship network connecting the top 25 collaborators of Nabih Maslah. A scholar is included among the top collaborators of Nabih Maslah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nabih Maslah. Nabih Maslah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ganesan, Saravanan, Fabien Guidez, Nabih Maslah, et al.. (2024). Comprehensive analysis of mesenchymal cells reveals a dysregulated TGF-β/WNT/HOXB7 axis in patients with myelofibrosis. JCI Insight. 9(23). 1 indexed citations

Ganesan, Saravanan, Evelyne Lauret, Nabih Maslah, et al.. (2024). Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms. Blood Cancer Journal. 14(1). 1–1. 5 indexed citations

Maslah, Nabih, Saravanan Ganesan, Robert L. Gendron, et al.. (2024). JAK2V617F‐dependent down regulation of SHP‐1 expression participates in the selection of myeloproliferative neoplasm cells in the presence of TGF‐β. Journal of Cellular and Molecular Medicine. 28(20). e70138–e70138. 3 indexed citations

Yang, Shujun, Guifang Ouyang, Michel Lepoivre, et al.. (2024). Targeting the redox vulnerability of acute myeloid leukaemia cells with a combination of auranofin and vitamin C. British Journal of Haematology. 205(3). 1017–1030. 2 indexed citations

Maslah, Nabih, Lina Benajiba, Stéphane Giraudier, Jean‐Jacques Kiladjian, & Bruno Cassinat. (2023). Clonal architecture evolution in Myeloproliferative Neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscape. Leukemia. 37(5). 957–963. 9 indexed citations

Maslah, Nabih, Emmanuelle Verger, Christine Chomienne, et al.. (2021). Revisiting Diagnostic performances of serum erythropoïetin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement. British Journal of Haematology. 196(3). 676–680. 7 indexed citations

Maslah, Nabih, Vahid Asnafi, Emmanuelle Six, et al.. (2021). Adenylate kinase 2 expression and addiction in T-ALL. Blood Advances. 5(3). 700–710. 6 indexed citations

Zhao, Lin‐Pierre, Nabih Maslah, Emmanuelle Verger, et al.. (2021). Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms. Blood. 138(21). 2142–2148. 20 indexed citations

Cazaux, Marine, Nabih Maslah, Emmanuelle Verger, et al.. (2021). Myeloproliferative Neoplasms (MPN) Clonal Evolution Landscape and Its Impact on Patients' Prognosis. Blood. 138(Supplement 1). 317–317. 2 indexed citations

10.

Maslah, Nabih, Emmanuelle Verger, Nathalie Parquet, et al.. (2021). Genomic Landscape and Clinical Features of Myeloproliferative Neoplasm (MPN) Patients with Auto-Immune and Inflammatory Diseases (AID). Blood. 138(Supplement 1). 1496–1496. 1 indexed citations

11.

Soret, Juliette, Nicolas Gauthier, Emmanuelle Verger, et al.. (2020). SF3B1 mutations in the Driver Clone Increase the Risk of Evolution to Myelofibrosis in Patients with Myeloproliferative Neoplasms (MPN). Blood. 136(Supplement 1). 1–1. 2 indexed citations

12.

Cassinat, Bruno, Barbara Mora, Emmanuelle Verger, et al.. (2020). Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses. Blood Advances. 4(15). 3708–3715. 30 indexed citations

13.

Maslah, Nabih, Valérie Edmond, Bruno Cassinat, et al.. (2020). JAK2V617F myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML. The Journal of Experimental Medicine. 218(2). 19 indexed citations

14.

Soret, Juliette, Nicolas Gauthier, Emmanuelle Verger, et al.. (2020). NFE2 Mutations Impact AML Transformation and Overall Survival in Patients with Myeloproliferative Neoplasms (MPN). Blood. 136(Supplement 1). 36–36. 2 indexed citations

15.

Verger, Emmanuelle, Nabih Maslah, Marie‐Hélène Schlageter, et al.. (2020). Pitfalls in CALR exon 9 mutation detection: A single‐center experience in 571 positive patients. International Journal of Laboratory Hematology. 42(6). 827–832. 3 indexed citations

16.

Gauthier, Nicolas, Emmanuelle Verger, Nabih Maslah, et al.. (2020). Interferon-Alpha (IFN) Therapy Discontinuation Is Feasible in Myeloproliferative Neoplasm (MPN) Patients with Complete Hematological Remission. Blood. 136(Supplement 1). 35–36. 24 indexed citations

17.

Maslah, Nabih, Emmanuelle Verger, Pierre Ly, et al.. (2019). Synergistic effects of PRIMA-1^Met (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia. Haematologica. 105(6). 1539–1551. 100 indexed citations

18.

Maslah, Nabih, Juliette Soret, Christine Dosquet, et al.. (2019). Masked polycythemia vera: analysis of a single center cohort of 2480 red cell masses. Haematologica. 105(3). e95–e97. 19 indexed citations

19.

Maslah, Nabih, Valérie Edmond, Bruno Cassinat, et al.. (2018). Specific and Synergistic Targeting of JAK2V617F Cells By Interferon Alpha and Arsenic. Blood. 132(Supplement 1). 52–52. 3 indexed citations

20.

Maslah, Nabih, Bruno Cassinat, Emmanuelle Verger, Jean‐Jacques Kiladjian, & Laura Evelia Torres Velázquez. (2017). The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders. Leukemia. 31(8). 1661–1670. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact